Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Equilibrium phase contrast-enhanced magnetic resonance angiography of the thoracic aorta and heart using balanced T1 relaxation-enhanced steady-state.
Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.
International trial of the Edmonton protocol for islet transplantation.
Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res. 1995 Oct; 1(10):1223-32.
View in:
PubMed
subject areas
Ascites
Calcium
Cell Division
Fatty Acids
Female
Growth Substances
Humans
Lysophospholipids
Mass Spectrometry
Neoplasm Proteins
Ovarian Neoplasms